Pricing Log in Create free account

Lyell Immunopharma, Inc. (LYEL) vs Tectonic Therapeutic, Inc. (TECX)

Lyell Immunopharma, Inc. and Tectonic Therapeutic, Inc. are both Biotechnology companies. Lyell Immunopharma, Inc. and Tectonic Therapeutic, Inc. are of similar size ($379.7M and $367.6M). Tectonic Therapeutic, Inc. has the higher net margin (0.00% vs −1,701,066.7%) and the higher return on invested capital (0.00% vs −1,070.8%). Across the 13 metrics below, Tectonic Therapeutic, Inc. leads on 11 and Lyell Immunopharma, Inc. on 2.

Valuation

Metric LYEL TECX Biotechnology median
P/E n/m n/m 10.60
P/S 24,142.77 n/m 9.40
P/B 1.88 1.75 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 12,335.70 n/m 9.02
Earnings yield (84.75%) (22.16%) (32.88%)
Free cash flow yield (49.94%) (18.51%) (23.13%)

Profitability

Metric LYEL TECX Biotechnology median
Gross margin 100.00% 0.00% 68.51%
Operating margin (1,783,580.00%) 0.00% 0.00%
Net margin (1,701,066.67%) 0.00% 0.00%
Free cash flow margin (928,333.33%) 0.00% 0.00%
Return on equity (97.79%) (33.80%) (51.96%)
Return on assets (74.85%) (32.23%) (46.06%)
Return on invested capital (1,070.83%) 0.00% 0.00%

Growth

Metric LYEL TECX Biotechnology median
Revenue growth (TTM) (63.41%) — 6.76%
EPS growth (last fiscal year) 38.70% 40.70% 29.88%
Revenue growth, 5-year CAGR (65.85%) — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric LYEL TECX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 4.02 22.29 4.97
Net debt to EBITDA 0.94 3.08 1.01

Dividend

Metric LYEL TECX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric LYEL TECX Biotechnology median
Market cap 367.57m 379.65m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack